Pharma & Biotech Mergers & Acquisitions News
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Today's issue
Refine Search
Latest Mergers & Acquisitions News & Features
Generics
Fast-growing contract development and manufacturing organization (CDMO), Bora Pharmaceuticals, has completed the acquisition of fellow Taiwan based TWi Pharmaceutical, a technology-based company specializing in development and commercialization of niche generic drugs. 13 September 2022
Generics
UK-based specialty pharmaceutical company CNX Therapeutics said this morning it has successfully completed the acquisition of Synchrony Pharma and its existing portfolio of commercialized products. 29 July 2022
Generics
Novartis has reported slightly lower than expected revenues for the second quarter, which came in at $12.78 billion, a 1% decline from the same period of last year. 19 July 2022
Generics
Following a public comment period, the USA’s Federal Trade Commission (FTC) has approved a final order settling charges that London-listed Jordanian drugmaker Hikma Pharmaceuticals’ $375 million acquisition of Custopharm likely would have harmed competition in the market for the corticosteroid drug triamcinolone acetonide, or TCA. 15 July 2022
Generics
Illinois, USA-based Long Grove Pharmaceuticals, founded in 2019 by strategic health care investor Water Street Healthcare Partners, will begin shipping its first products in mid-2022. 22 April 2022
Generics
The US Federal Trade Commission on Tuesday said it required – as a condition of London-listed Jordanian drugmaker Hikma Pharmaceuticals’ $375 million acquisition of Custopharm announced in September 2021 – that Custopharm’s parent company retain and transfer Custopharm’s assets related to the corticosteroid drug triamcinolone acetonide, or TCA, to another subsidiary, Long Grove Pharmaceuticals. 20 April 2022
Generics
India's pharmaceutical sector is seeing a lot of M&A and fund-raising activity. 15 February 2022
Generics
Texas, USA-based Mark Cuban Cost Plus Drug Company (MCCPDC) officially launched its online pharmacy yesterday. The launch comes just weeks after its pharmacy benefit manager (PBM) operation was established - both critical efforts in the company's pursuit to help shield consumers from inflated drug prices. 28 January 2022
Generics
India's domestic drug firms with active pharmaceutical ingredient (API) assets appear to be attracting interest. A case in point is Mumbai-based generic drugs manufacturer BDR Pharmaceuticals. 25 January 2022
Generics
London-listed Jordanian drugmaker Hikma Pharmaceuticals has launched a new outsourced sterile compounding business, called Hikma 503B. 10 January 2022
Generics
China’s Pharmaron Beijing has acquired Aesica Pharmaceuticals (the Cramlington Site) from Swedish Contract Development and Manufacturing Organization (CDMO) Recipharm group. 10 January 2022
Generics
Hyderabad, India-based Natco Pharma is to acquire Dash Pharmaceuticals, a front-end pharmaceutical sales, marketing and distribution entity based in New Jersey, USA, with net sales of $15 million expected for the year ending December 2021. 16 December 2021
Generics
The US Federal Trade Commission will require generic drug marketers ANI Pharmaceuticals and Novitium Pharma to divest, to Prasco, ANI’s development rights to one generic drug used to treat common infections and assets with respect to another generic drug used to treat inflammation as part of a settlement resolving charges that ANI’s $210 million acquisition of Novitium, announced in March this year, likely would be anticompetitive. 11 November 2021
Generics
London-listed drugmaker Hikma Pharmaceuticals, one of the largest suppliers of generic injectable medicines in the USA, plans to acquire Custopharm. 28 September 2021
Generics
Ardena, a Belgian pharmaceutical ctract development and manufacturing Organization (CDMO), says it has acquired Idifarma, a Spain-based contract manufacturer of niche and highly potent generic and innovative drugs. 2 September 2021
Generics
Dutch drugmaker Centrient Pharmaceuticals, an antibiotics manufacturer wholly-owned by Bain Capital, has acquired Vadodara, India-based Astral SteriTech, a manufacturer in sterile antibiotic injectable finished dosage forms. 1 September 2021
Generics
The European Commission has approved, under the EU Merger Regulation, the acquisition of joint control of Lonza Specialty Ingredients of Switzerland by USA-based Bain Capital Investors and Cinven Capital Management of the UK. 21 June 2021
Generics
Piramal Pharma Limited’s contract development and manufacturing organization (CDMO), Piramal Pharma Solutions (PPS), has entered into an agreement to acquire a 100% stake in fellow India-based Hemmo Pharmaceuticals. 1 April 2021
Generics
The recent merger of Mylan and Upjohn was one of the biggest in healthcare. But in their rebirth as Viatris (Nasdaq: VTRS), a lesson about the future of the industry may be in rediscovering its humanity, writes Christina Falzano, managing director, Conran Design Group, in an Expert View piece. 19 February 2021
Generics
Bangladesh's largest drugmaker Beximco Pharmaceuticals has entered into a binding commitment with France’s Sanofi regarding the acquisition of a majority stake in Sanofi Bangladesh. 21 January 2021
Generics
Aspire Pharma, a UK-based niche generics business, has announced the acquisition of all assets from Canute Pharma, further expanding its product range. 4 October 2024
Generics
Viatris has announced that the antitrust division of the US Department of Justice (DOJ) has concluded its investigation into Mylan and its former president, Rajiv Malik. 3 July 2024
Generics
An activist investor has renewed its effort to prevent Taro Pharmaceutical from accepting a buyout bid from Sun Pharmaceutical. 24 April 2024
Generics
Generic drugmaker Apotex has reached an agreement to acquire fellow Canada-based Searchlight Pharma. 5 April 2024
Generics
KELIX bio, an emerging markets biopharmaceuticals platform, has been sold to Mubadala Investment Company, an Abu Dhabi investor with over $276 billion in assets under management. 25 March 2024
Generics
Generic drugmaker Aspire Pharma today announced the successful completion of its acquisition of fellow UK-based Cenoté Pharma, in continuation of its strong organic growth. 11 March 2024
Generics
In a bid to focus on growth and innovation, Israeli generics drugmaker Teva Pharmaceutical is to hive off its active pharmaceutical ingredient (API) business. 1 February 2024
Generics
Sun Pharmaceutical Industries of India announced its intention to acquire all outstanding shares of US generics drugmaker Taro Pharmaceutical Industries at a price of $43 per share in cash, the companies announced. 19 January 2024
Generics
Taiwan’s Bora Pharmaceuticals is to acquire Upsher-Smith Laboratories, a US generics manufacturer. 17 January 2024
Generics
South Africa's largest drugmaker Aspen Pharmacare has announced an agreement with newly-independent generics drugmaker Sandoz, related to its Chinese business. 7 December 2023
Generics
Portuguese contract development and manufacturing organization (CDMO) Hovione has acquired the start-up ExtremoChem for an undisclosed amount. 20 November 2023
Generics
The Indian pharma and healthcare sector has witnessed a 298% jump in deals during the third quarter of 2023 compared to the same period last year. 8 November 2023
Generics
A confluence of factors is creating a conducive environment for mergers and acquisitions (M&As) to pick up pace in India. 23 October 2023
Generics
USA-based drugmaker Viatris has announced a series of divestitures as part of a strategy to narrow the company’s focus. 3 October 2023
Generics
Indian drugmaker Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma Limited to divest a 75% stake in its subsidiary, Glenmark Life Sciences Limited (GLS), which focuses on producing active pharmaceutical ingredients (APIs). 22 September 2023
Generics
Shares of Hyderabad, India-headquartered Suven Pharmaceuticals hit a fresh 52-week high on the bourses after the Indian government gave the green signal to foreign direct investment (FDI) of up to $1.15 billion by drug major Cyprus-based Berhyanda. 19 September 2023
Generics
Several international investors and fund managers have expressed an interest in investing in the Indian pharmaceutical and biotechnology sectors, underlining the need to establish a platform to facilitate the transition of global capital flows into the domestic economy. 14 April 2023
Generics
In what could well be India's biggest pharma deal, China's Fosun Pharma-owned Gland Pharma is on the block. A number of private equity firms have been approached, including Baring Private Equity, Bain Capital, Blackstone, Carlyle, and KKR. 19 December 2022
Generics
Generics major Viatris yesterday said it intends to create an ophthalmology franchise by acquiring two companies, Oyster Point Pharma (Nasdaq: OYST) and Famy Life Sciences. 8 November 2022
Generics
Private equity firm SK Capital Partners has entered into a deal to acquire Apotex Pharmaceutical Holdings, a Canada-based generic drugmaker with products across all major therapeutic areas for patients around the world. 29 September 2022
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze